## FFIV: F5, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -0.8% below STRENGTH zone (3.0-6.0%); PEG 2.04 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($249.55)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 10)

**1. FFIV Investors Have Opportunity to Lead F5, Inc. Securities Fraud Lawsuit**
- Source: PR Newswire | 20251224T220827 | Bearish | Relevance: 100%
- The Rosen Law Firm announces a class action lawsuit against F5, Inc. (NASDAQ: FFIV) on behalf of investors who purchased securities between October 28, 2024, and October 27, 2025. The lawsuit alleges that F5 misled investors about its revenue outlook and growth, while downplaying a significant security incident. Investors have until February 17, 2026, to move the Court to serve as lead plaintiff.

**2. F5, Inc. (FFIV) Faces Securities Class Action Amid Cybersecurity Incident, Questions About Disclosure Timing and Impact on Company's Business - Hagens Berman**
- Source: Morningstar | 20251224T190803 | Bearish | Relevance: 100%
- F5, Inc. (FFIV) is facing a securities class action lawsuit filed by Hagens Berman on behalf of investors who purchased shares between October 28, 2024, and October 27, 2025. The lawsuit stems from a cybersecurity incident involving a nation-state actor earlier in 2025 that gained unauthorized access to F5 systems, including its highest-revenue product, F5 BIG-IP. Investors suffered significant losses following disclosures about the breach and its material impact on the company's financial outlook, with Hagens Berman investigating whether F5 timely reported the breach to investors.

**3. Bronstein, Gewirtz & Grossman LLC Urges F5, Inc. Investors to Act: Class Action Filed Alleging Investor Harm**
- Source: PR Newswire | 20251224T170803 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman LLC has announced a class action lawsuit against F5, Inc. (NASDAQ: FFIV) and its officers, alleging violations of federal securities laws. The lawsuit claims F5 made misleading statements and concealed a significant security breach affecting key product offerings, leading to artificially inflated stock prices for investors. Shareholders who purchased F5 securities between October 28, 2024, and October 27, 2025, are encouraged to join the case, with a lead plaintiff deadline of February 17, 2026.

**4. Deadline Approaching: F5, Inc. (FFIV) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith**
- Source: FinancialContent | 20251224T123000 | Bearish | Relevance: 100%
- The Law Offices of Howard G. Smith are urging F5, Inc. (FFIV) shareholders who incurred losses between October 28, 2024, and October 27, 2025, to contact them regarding an upcoming lead plaintiff deadline of February 17, 2026. This action stems from a securities fraud lawsuit alleging F5 made misleading statements and failed to disclose a significant security incident that impacted its systems and operations, leading to stock price drops. Investors are encouraged to learn more about participating in the class action lawsuit.

**5. ROSEN, GLOBAL INVESTOR COUNSEL, Encourages F5, Inc. Stockholders to Secure Counsel Before Important Deadline in Securities Class Action - FFIV**
- Source: GlobeNewswire | 20251224T022941 | Bearish | Relevance: 100%
- Rosen Law Firm has announced a class action lawsuit against F5, Inc. (NASDAQ: FFIV) on behalf of investors who purchased securities between October 28, 2024, and October 27, 2025. The lawsuit alleges that F5 created a false impression of its revenue outlook and growth while minimizing risks, and that a security incident contradicted its claims of best-in-industry security. Investors have until February 17, 2026, to move the Court to serve as lead plaintiff.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $296 | $336 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($0.00M) |
| Sells | 18 ($3.55M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (-2.1%)
- Blackrock Inc.: 11.0% (-1.9%)
- Hotchkis & Wiley Cap: 8.3% (-7.5%)
- State Street Corpora: 5.5% (+1.7%)
- Geode Capital Manage: 3.0% (+1.7%)

### Key Risks

1. Insider selling cluster: $3.5M in recent transactions.
2. Long-term trend broken: trading 8.1% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.04 elevated, pricing in significant growth expectations. Forward P/E 16.2x stretched relative to 8% growth. Quality metrics strong (ROE 21%, margin 22%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($3.5M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $15.2B |
| Beta | 0.99 |
| 52W Range | $223.76 - $346.00 |
| Short Interest | 7.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.04 |
| Forward P/E | 16.2 |
| Current P/E | 17.5 |
| YoY Growth | 7.8% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 1.9% to -0.8% (-2.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.8pp (needs >3.0% for momentum thesis). Below SMA200 (0.92x), long-term trend not supportive. MACD histogram positive (1.82), confirming momentum. RSI neutral at 59. OFD pattern: +MLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.77% (CS: 54) | Neutral |
| RSI_14 | 59.1 | Neutral |
| MACD Histogram | 1.82 | Bullish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 1.021x | Above |
| vs SMA200 | 0.919x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $262.33
- **Stop Loss:** $249.55 (4.9% risk)
- **Target:** $275.11 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 93
- **Position Value:** $24,396.69
- **Portfolio %:** 24.40%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-01-27 (Est: $3.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.97 | $4.39 | +10.6% |
| 2025Q2 | $3.49 | $4.16 | +19.2% |
| 2025Q1 | $3.09 | $3.42 | +10.5% |
| 2024Q4 | $3.38 | $3.84 | +13.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*